Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07686692 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency

Name: IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency — clinical trial record (NCT07686692)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: INFUSE-HFpEF

StatusNot Yet Recruiting

PhasePhase 4

SponsorDuke University

Started2026-08

View on ClinicalTrials.gov ↗

Duke University

455 trials monitored

See 53 trials at risk

Heart Failure

1,854 trials monitored

See 95 trials at risk

This randomized, double-blind, placebo-controlled clinical trial evaluates intravenous ferric derisomaltose in older adults with HFpEF and iron deficiency.

Trial Details

NCT Number	NCT07686692
Lead Sponsor	Duke University Collaborators: National Institutes of Health (NIH), National Institute on Aging (NIA), Kaiser Permanente
Conditions	Heart Failure With Preserved Ejection Fraction, Iron Deficiency
Enrollment	300 participants
Start Date	2026-08
Primary Completion	2030-08 (estimated)
Study Completion	2030-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-07